Emergent BioSolutions CFO to Retire; Interim Successor Named
CFO Richard S. Lindahl will retire effective Dec. 31, 2026. VP and Treasurer Frank Vargo will become interim CFO on Jan. 1, 2027, and Lindahl will advise through Mar. 31, 2027.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.